Orally administered emu oil decreases acute inflammation and alters selected small intestinal parameters in a rat model of mucositis.

@article{Lindsay2010OrallyAE,
  title={Orally administered emu oil decreases acute inflammation and alters selected small intestinal parameters in a rat model of mucositis.},
  author={Ruth J. Lindsay and Mark S. Geier and Roger Yazbeck and Ross Norman Butler and Gordon S Howarth},
  journal={The British journal of nutrition},
  year={2010},
  volume={104 4},
  pages={
          513-9
        }
}
Mucositis resulting from cancer chemotherapy is a serious disorder of the alimentary tract. Emu oil has demonstrated anti-inflammatory properties in animal models of arthritis and wound healing; however, its effects on the intestine remain unknown. We investigated emu oil for its potential to decrease the severity of mucositis in a rat model. Female Dark Agouti rats (110-150 g) were orogastrically gavaged with emu oil (0.5 or 1 ml) or water (1 ml) for 5 d before intraperitoneal injection of 5… 

Figures and Tables from this paper

Emu Oil Combined with Lyprinol™ Reduces Small Intestinal Damage in a Rat Model of Chemotherapy-Induced Mucositis
TLDR
Emu Oil combined with Lyprinol™ partially reduced acute small intestinal inflammation in rats, suggesting that isolating bioactive constituents of these naturally sourced oils could provide a more targeted strategy to protect against intestinal mucositis.
Emu oil expedites small intestinal repair following 5-fluorouracil-induced mucositis in rats
TLDR
Promotion of repair from injury could represent a new mechanism of action for EO, suggesting potential as an adjunct to conventional treatment approaches for cancer management.
Emu Oil Reduces Small Intestinal Inflammation in the Absence of Clinical Improvement in a Rat Model of Indomethacin-Induced Enteropathy
TLDR
EO reduced acute intestinal inflammation, whereas other parameters of Indomethacin-induced intestinal injury were not affected significantly, and increased EO dose and/or frequency of administration could potentially improve clinical efficacy.
Intestinal homeostasis is restored in mice following a period of intestinal growth induced by orally administered Emu Oil
TLDR
The restoration of normal intestinal architecture following cessation of Emu Oil therapy supports its safety for application in intestinal disorders and indicates that controlled inflammation and intestinal proliferation can predispose to the development of colorectal cancer.
Orally administered emu oil attenuates disease in a mouse model of Crohn’s-like colitis
TLDR
Emu oil reduced overall disease severity and facial grimace scores in TNBS mice, suggesting therapeutic potential for orally administered emu oil in the management of Crohn’s disease.
Anti-inflammatory Activity of Emu Oil in Indomethacin Induced Inflammatory Bowel Disease in Rats
TLDR
It was concluded that emu oil might be attempted to treat the inflammatory conditions of gastro-intestinal tract as a part of alternative medicine.
A new animal model of intestinal mucositis induced by the combination of irinotecan and 5-fluorouracil in mice
TLDR
A new experimental model of IM induced by combining irinotecan and 5-FU treatments is developed, which will allow for a better knowledge concerning the pathogenesis of this disease through the pharmacological modulation of key inflammatory mediators.
Dietary emu oil supplementation suppresses 5-fluorouracil chemotherapy-induced inflammation, osteoclast formation, and bone loss.
TLDR
It is demonstrated that EO can counter 5-FU chemotherapy-induced inflammation in bone, preserve osteoblasts, suppress osteoclast formation, and potentially be useful in preventing 5-fluorouracil chemotherapy- induced bone loss.
Chimonanthus nitens var. salicifolius Aqueous Extract Protects against 5-Fluorouracil Induced Gastrointestinal Mucositis in a Mouse Model
  • Zhenze Liu, Jun Xi, J. Fei
  • Biology, Medicine
    Evidence-based complementary and alternative medicine : eCAM
  • 2013
TLDR
It is concluded that CS could protect mice against 5-Fu induced mucositis by inhibiting apoptosis and inflammation, and this protective effect might be associated with the 3 flavonoids identified in CS aqueous extract.
Emu Oil Increases Colonic Crypt Depth in a Rat Model of Ulcerative Colitis
TLDR
Emu oil improved tissue damage associated with colitis, suggesting its potential as a unique formulation to augment conventional treatment approaches for IBD.
...
...

References

SHOWING 1-10 OF 33 REFERENCES
Lyprinol™ only partially improves indicators of small intestinal integrity in a rat model of 5-fluorouracil-induced mucositis
TLDR
Lyprinol™ treatment in rats with 5-FU-induced mucositis only minimally decreased indicators of intestinal integrity, and further studies of marine oils high in omega-3 PUFA content are warranted for the potential prophylactic treatment of intestinal mucositIS.
Effect of emu oil on auricular inflammation induced with croton oil in mice.
TLDR
Topically applied emu oil significantly reduced severity of acute auricular inflammation induced by croton oil in mice.
Antagonism of croton oil inflammation by topical emu oil in CD-1 mice
TLDR
It is indicated that topical emu oil has anti-inflammatory properties in the CD-1 mouse that are associated with decreased auricular thickness and weight, and with the cytokines IL-1α and TNF-α.
Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats.
TLDR
It is concluded that oral whey growth factor extract reduces methotrexate-induced damage in the small bowel, which suggests clinical applications for the treatment of intestinal mucositis.
Velafermin improves gastrointestinal mucositis following irinotecan treatment in tumor-bearing DA rats
TLDR
Rats that received velafermin prior to, or prior to and during irinotecan treatment did develop severe or moderate diarrhoea, however it occurred later, in fewer rats and was not associated with mortality, and other dosing regimens were not as effective.
Palifermin reduces diarrhea and increases survival following irinotecan treatment in tumor‐bearing DA rats
TLDR
Palifermin pretreatment in both treatment regimens significantly reduces diarrhea and mortality following irinotecan administration without adversely affecting tumor growth.
[Anti-inflammatory activity and healing-promoting effects of topical application of emu oil on wound in scalded rats].
TLDR
Emu oil has topical anti-inflammatory activity in rats with superficial II degree scald, possibly in association with decreased levels of the proinflammatory cytokines in the tissues and can promote wound healing by inhibiting local secondary inflammation.
...
...